On this episode, you’ll hear from Kenneth Davis, M.D., president and CEO of Mount Sinai Health System in New York, a system that was on the front lines of the first wave of COVID-19. He is a neurobiologist and a pioneering researcher in the field of brain disease, notably Alzheimer’s disease.

Dr. Davis discusses lessons learned during the COVID-19 pandemic and how to better prepare for further surges or another virus. In our conversation he says, “We just need to be ready,” emphasizing the necessity for the U.S. to be a leader in responding to a future global pandemic, including on diagnostic testing and vaccines.

Responding to a public health emergency of this scale reveals the benefits of working and collaborating in a large, integrated health system. Dr. Davis reflects on his system’s experience and on a range of related topics including health care inequities, social determinants of health, and using a population health model to provide care and keep people well.

Look for more of my conversations on trending topics with health care leaders from around the country, released as part of the Chair File.

Rod Hochman, M.D.
AHA Chair

 

 

Related News Articles

Headline
Joseph A. Miller, a nationally recognized behavioral health expert and past chair of the AHA’s Constituency Section for Psychiatric and Substance Abuse…
Headline
Commenting on a forthcoming Centers for Medicare & Medicaid Services’ rule requiring COVID-19 vaccinations for workers in most health care settings…
Chairperson's File
On this episode, I discuss emergency preparedness, caregiver resiliency and health equity — all through the lens of the COVID-19 pandemic — with Fritz Francois…
Headline
The Colorado Hospital Association today named Maryjane Wurth its interim president and CEO. Wurth, who was AHA’s executive vice president and chief operating…
Headline
The Centers for Medicare & Medicaid Services today announced that the agency will pay for Medicare beneficiaries’ booster doses, without cost sharing…
Headline
AHA today urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure…